SHANGHAI – Despite a year in which China's venture investors raised a highest-ever $42.8 billion to invest in life sciences companies, deploying a record sum globally, superlatives about the nation's supersized investment activity can wear thin. Inviting a closer look, Chinabio Group founder and CEO Greg Scott enlisted a panel of key VCs to examine the unfolding dynamics during the Chinabio Partnering Forum.